and healthcare worker's hands (44), 31 (30%) and 2 (5%) respective samples yielded MDR Acinetobacter spp. Among the environmental samples, 90% were from respiratory-related equipment. The majority of clinical and environmental MDR Acinetobacter spp. 
INTRODUCTION
Acinetobacter spp. is an important nosocomial pathogen with an increase in resistance to multiple antimicrobial agents.
Multidrug resistance (MDR) is defined as the resistance to representative antimicrobial agents of at least three different classes. The most commonly included antimicrobials are aminoglycosides, antipseudomonal penicillins, carbapenems, cephalosporins, and quinolones. The suggested definition of extreme drug resistance (XDR) in Acinetobacter spp. included resistance to sulbactam, minocycline or doxycycline, and tigecycline in addition to the above mentioned antimicrobials. Furthermore, pandrug resistance (PDR) is defined as resistance to tigecycline and polymyxins along with the above mentioned antimicrobials [1] .
Acinetobacter spp. is intrinsically less susceptible to antibiotics than Enterobacteriaceae, and has the propensity to acquire resistance [1, 2] . Fournier, et al. [3] detected 45 acquired resistance genes in a MDR Acinetobacter baumannii, which were localized to the AbaR1 resistance island. The genetic surroundings of these resistance determinants provided more evidence for genetic promiscuity, with an array of broad-host-range mobile genetic elements identified, including three class 1 integrons, transposons, and insertion sequence (IS) elements.
A surveillance study in Korea in 2009 showed that resistance rates of Acinetobacter spp. were very high for fluoroquinolone (67%), amikacin (48%), ceftazidime (66%) and imipenem (51%) [4] . In The Surveillance Network study in the U.S, the resistance trend of A. baumannii was largely similar to that in Korea [5] . [7, 8] . Twenty-eight MDR Acinetobacter isolates were randomly selected for further investigation.
The environmental samples from fomite and instruments in the ICUs were cultured to find the source of the MDR Acinetobacter strains. A detailed list of the samples includes ventilator, circuit, mask, O2 meter, suction regulator, suction bottle, suction cup, suction cart, ambu bag, intra-venous pump machines, bed-side guard rails, and window sill around suction equipments. In addition, samples from the hands of 44 healthcare workers (HCWs; 3 physicians, 31 nurses, and 10 cleaners working in the ICUs) were also cultured. Among the environmental isolates, 27 strains were randomly selected for further investigation.
Typing using pulsed-field gel electrophoresis (PFGE)
To determine the relatedness of 55 MDR Acinetobacer isolates between the environment and clinical samples, comparision of their PFGE patterns of SmaI-restricted genome was carried out. SmaI-restricted genomic DNA from Acinetobacter isolates was separated by PFGE using a CHEF-DR II system (Bio-Rad, Hercules, CA, USA) according to the manufacturer's protocol.
The band patterns were analyzed according to the Tenover criteria [9] .
Detection of OXA-type carbapenemase genes and ISAba1
OXA carbapenemase genes were detected by multiplex PCR, as previously reported [10] [11] [12] . OXA carbapenemas genes were sequenced using amplicons generated with the following pri- The resistance rate to carbapenem was also increased to more than 50%. More than 60% of the total isolates were from respiratory specimens.
Infection control intervention
After recognition of the outbreak, infection control interventions were enforced more strictly since October 2008. The infection control efforts focused primarily on respiratory equipments because most of the Acinetobacter isolates were obtained from the respiratory specimens. Closed-suction system was introduced and the equipments used for suction, including cups and catheters, were prevented from contact with the contaminated environments prior to the usage. Hand hygiene was also emphasized. A task force team was organized to improve the hand-washing rates. Adherence to hand washing was monitored daily and provided on site. Furthermore, the team educated HCWs to encourage a behavior change through an improved understanding of the importance of the infection control measures.
RESULTS

Outbreak description
The laboratory data from 2008 show a noticeable increase in Acinetobacter spp. isolation in the hospital; the number of patients of Acinetobacter isolates significantly increased from 62 in January to 168 in August, 2008 (Fig. 1) . The isolates from the ICU patients also increased from 26% to 40% (data not shown). More than 60% of the total isolates were from respiratory specimens. The number of Acinetobacter spp. isolated from clinical samples in the hospital was substantially reduced in October and November. However, the number of isolates increased again in December despite of the continuous effort to control the outbreak.
MDR Acinetobacter isolates from clinical and environmental samples and antimicrobial susceptibility testing
In September 2008, resistance rates of Acinetobacter isolates from clinical samples were 40% to imipenem, 47% to amikacin and 53% to levofloxacin. Among them, 21% were resistant to all 13 antimicrobial agents tested.
Of the 105 ICU environmental and 44 health-care worker's hand samples taken in October, 31 (30%) and 2 (5%) samples yielded MDR Acinetobacter spp., respectively ( Table 1 ). The rate of MDR Acinetobacter spp. isolate from respiratory tract related instruments (38%) was much higher than those from formite (10%) and HCWs' hands (5%).
All of randomly selected 55 MDR Acinetobacter isolates (28 clinical isolates and 27 environmental isolates) were positive for Modified-Hodge test and negative for double disk synergy test using imipenem-EDTA plus sodium mercaptoacetic acid disks, which suggested presence of carbapenemase other than metalo-beta-lactamases (MBLs).
Intensive cleaning of the respiratory equipments and fomite in the ICUs with antiseptic solutions, and encouraging the hand washings resulted in a substantial decrease in MDR Acineto- Fig. 2 . PFGE patterns of Acinetobacter spp. isolates from ICU environment (A) and patients (B). The majority of the isolates from ICU environment and patients belonged to pulsotype A, indicating they are identical clones. bacter isolation from respiratory tract samples, from 38% in October to 28% in November and 21% in December (Table 1) .
Analysis of PFGE patterns and carbapenemase genes
Analysis of the PFGE results showed similar band patterns indicating the isolates are clonally related. The majority of the isolates from respiratory equipments and patients belonged to pulsotype A, indicating they are identical clones (Fig 2, Table   2 ). All of pulsotype A strains were positive for blaOXA-51-like and blaOXA-23-like genes, which suggested that they were A. baumannii and imipenem resistance were due to OXA-23 production. There were some sporadic clones harboring blaOXA-182 and ISAba1-associated blaOXA-51 only (Table 2) . Considering the PFGE pattern with OXA carbapenemase results indicated that the major imipenem resistance mechanism was OXA-23 production.
DISCUSSION
In this study, the majority of MDR Acinetobacter isolates from the patients and the environment, most importantly respiratory equipments, belonged to a single clone, pulsotype A. This finding suggests that the strains had been mostly transmitted via direct contact with respiratory droplets.
Majority of the MDR Acinetobacter isolates had blaOXA-23-like
and blaOXA-51-like genes without ISAba1 insertion, which indicated that they were A. baumannii and the overproduction of the OXA-23 was the major mechanism for their carbapenem resistance. Outbreaks of OXA-type carbapenemase-producing Acinetobacter strains have been reported worldwide [1, 2] . In re-cent studies, blaOXA-23-like genes were the most prevalent among carbapenem-nonsusceptible isolates of Acinetobacter spp. from hospitals [1, 12, 13] . Another major mechanism for carbapenem resistance in Acinetobacter spp. in Korea is ISAba1-activated blaOXA-51-like genes [1, 10, 12, 13] . However, in this study, only two isolates from the patients and the environment showed the upstream presence of ISAba1. 
